Kiran U, Amin P, Penketh R J
Department of Obstetrics and Gynaecology, University Hospital of Wales, Cardiff, UK.
J Obstet Gynaecol. 2004 Feb;24(2):155-6. doi: 10.1080/01443610410001645451.
We conducted a retrospective study to determine the efficacy and safety of self-administration of vaginal misoprostol (following oral mifeprestone) for medical termination of pregnancy. This study revealed that self-administration was accepted by the majority of the patients (90%) and the success rate (98.4%) and duration of hospital stay was not altered significantly compared to our previous year's data, where women were administered vaginal misoprostol by the staff. Based on this study's results, we are of the opinion that this regimen not only demedicalises the problem but also decreases the workload for the medical staff.
我们进行了一项回顾性研究,以确定口服米非司酮后自行阴道给药米索前列醇用于药物终止妊娠的有效性和安全性。该研究表明,大多数患者(90%)接受自行给药,与我们前一年的数据相比,成功率(98.4%)和住院时间没有显著变化,前一年是由工作人员为女性阴道给药米索前列醇。基于这项研究的结果,我们认为这种给药方案不仅使问题非医疗化,还减轻了医务人员的工作量。